Clinical Trial Update: Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 study evaluating boceprevir-based triple therapy for HIV-positive patients with chronic hepatitis C has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Markus Peck-Radosavljevic | Conditions: Hepatitis C, Chronic, HIV | Phase 4 | Status: COMPLETED | Results posted: 2017-02-09